Munafa Stock Market Course + Intraday & FNO calls 
Champions Oncology (CSBR) Technical (Analysis) Reports Champions Oncology ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Champions Oncology (CSBR)
Technical Analysis Report for USA stock CSBR Champions Oncology. Dated: 12 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CSBR Champions Oncology then click here. or read Experts views on Champions Oncology or Forecast & share price targets of Champions Oncology
Champions Oncology Opened at 6.22 and Closed at: 6.72, which is 6.25% of previous session's close. It moved within a range of 6.22 and 7.00
The session was a Bullish session with an average volume of 12700, which is 70.08% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 6.47 and resistance for tomorrow is 7.25
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 6.29, 5.87 resistance for tomorrow's hourly charts is 7.07, 7.43
10 Day SMA for Champions Oncology (CSBR) is 6.19 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Champions Oncology (CSBR) is 6.43 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Champions Oncology (CSBR) is 6.59 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 6.64 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Champions Oncology is 7.22 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Champions Oncology is at 6.43 and 200 DMA is at 7.22, while 50 DMA and 100 DMA are at 6.59 and 6.64 respectively
Champions Oncology (CSBR) moving average of 20 SMA is at 6.43 and 20 EMA is at 6.41
| Date | Closing Price | 20 SMA | 20 EMA |
| 12 Fri Dec | 6.72 | 6.43 | 6.41 |
| 11 Thu Dec | 6.30 | 6.44 | 6.38 |
| 10 Wed Dec | 6.16 | 6.47 | 6.39 |
| 09 Tue Dec | 6.27 | 6.51 | 6.41 |
| 08 Mon Dec | 6.26 | 6.54 | 6.42 |
| 05 Fri Dec | 6.04 | 6.56 | 6.44 |
Champions Oncology (CSBR) moving average of 50 SMA is at 6.59 and 50 EMA is at 6.56
| Date | Closing Price | 50 SMA | 50 EMA |
| 12 Fri Dec | 6.72 | 6.59 | 6.56 |
| 11 Thu Dec | 6.30 | 6.58 | 6.55 |
| 10 Wed Dec | 6.16 | 6.58 | 6.56 |
| 09 Tue Dec | 6.27 | 6.59 | 6.58 |
| 08 Mon Dec | 6.26 | 6.59 | 6.59 |
| 05 Fri Dec | 6.04 | 6.59 | 6.6 |
Champions Oncology (CSBR) moving average of 100 SMA is at 6.64 and 100 EMA is at 6.74
| Date | Closing Price | 100 SMA | 100 EMA |
| 12 Fri Dec | 6.72 | 6.64 | 6.74 |
| 11 Thu Dec | 6.30 | 6.65 | 6.74 |
| 10 Wed Dec | 6.16 | 6.66 | 6.75 |
| 09 Tue Dec | 6.27 | 6.68 | 6.76 |
| 08 Mon Dec | 6.26 | 6.7 | 6.77 |
| 05 Fri Dec | 6.04 | 6.72 | 6.78 |
Champions Oncology (CSBR) moving average of 200 SMA is at 7.22 and 200 EMA is at 6.8
| Date | Closing Price | 200 SMA | 200 EMA |
| 12 Fri Dec | 6.72 | 7.22 | 6.8 |
| 11 Thu Dec | 6.30 | 7.24 | 6.8 |
| 10 Wed Dec | 6.16 | 7.25 | 6.8 |
| 09 Tue Dec | 6.27 | 7.27 | 6.81 |
| 08 Mon Dec | 6.26 | 7.29 | 6.82 |
| 05 Fri Dec | 6.04 | 7.31 | 6.83 |
Takeda Pharmaceutical has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 1.46% more returns!
Penumbra Inc has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Penumbra Inc, about 12.59% more returns!
Hca Healthcare has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Hca Healthcare, about 3.74% more returns!
Champions Oncology has performed better than Encompass Health in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Abbvie Inc in short term. Holding Champions Oncology could be a better choice for now!
Verrica Pharmaceuticals has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Verrica Pharmaceuticals, about 102.71% more returns!
Twist Bioscience has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Twist Bioscience, about 16.29% more returns!
Myriad Genetics has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Myriad Genetics, about 8.63% more returns!
Mannkind Corporation has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Mannkind Corporation, about 18.57% more returns!
Champions Oncology has performed better than Mustang Bio in short term. Holding Champions Oncology could be a better choice for now!
Insmed Inc has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Insmed Inc, about 3.14% more returns!
Inogen Inc has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Inogen Inc, about 3.5% more returns!
Dexcom Inc has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Dexcom Inc, about 16.51% more returns!
Champions Oncology has performed better than Dermira Inc in short term. Holding Champions Oncology could be a better choice for now!
Cerus Corporation has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Cerus Corporation, about 35.75% more returns!
Bioxcel Therapeutics has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Bioxcel Therapeutics, about 24.49% more returns!
Champions Oncology has performed better than Anixa Biosciences in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Amphastar Pharmaceuticals in short term. Holding Champions Oncology could be a better choice for now!
Akebia Therapeutics has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Akebia Therapeutics, about 0.58% more returns!
Champions Oncology Technical analysis of indicators
Price action analysis of Champions Oncology (CSBR) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Champions Oncology stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Champions Oncology in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Champions Oncology Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Champions Oncology in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Champions Oncology is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.17 and Champions Oncology CSBR stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Champions Oncology CSBR stock. Volume based technical analysis of Champions Oncology CSBR stock is negative.
Champions Oncology Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CSBR Champions Oncology These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CSBR Experts View which covers a lot of information including buying and selling signals
CSBR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Champions Oncology or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Champions Oncology (CSBR) Technical (Analysis) Reports Champions Oncology ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
